Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Promotion of prescription drugs to consumers and providers, 2001-2010.

Kornfield R, Donohue J, Berndt ER, Alexander GC.

PLoS One. 2013;8(3):e55504. doi: 10.1371/journal.pone.0055504. Epub 2013 Mar 4.

2.

Trends in direct-to-consumer advertising of prescription contraceptives.

Wu MH, Bartz D, Avorn J, Seeger JD.

Contraception. 2016 May;93(5):398-405. doi: 10.1016/j.contraception.2016.01.010. Epub 2016 Jan 22.

PMID:
26808088
3.

A statistical analysis of the magnitude and composition of drug promotion in the United States in 1998.

Ma J, Stafford RS, Cockburn IM, Finkelstein SN.

Clin Ther. 2003 May;25(5):1503-17.

PMID:
12867225
4.

Promotion of prescription drugs to consumers.

Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM.

N Engl J Med. 2002 Feb 14;346(7):498-505.

5.

Market Exclusivity Time for Top Selling Originator Drugs in Canada: A Cohort Study.

Lexchin J.

Value Health. 2017 Sep;20(8):1139-1142. doi: 10.1016/j.jval.2017.05.004. Epub 2017 Jun 20.

PMID:
28964446
6.

Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative.

Majumdar SR, Almasi EA, Stafford RS.

JAMA. 2004 Oct 27;292(16):1983-8.

PMID:
15507584
7.

Generic entry, reformulations and promotion of SSRIs in the US.

Huskamp HA, Donohue JM, Koss C, Berndt ER, Frank RG.

Pharmacoeconomics. 2008;26(7):603-16.

8.

Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale.

Mintzes B, Morgan S, Wright JM.

PLoS One. 2009 May 27;4(5):e5699. doi: 10.1371/journal.pone.0005699.

9.
10.

Direct marketing of pharmaceuticals to consumers.

Lyles A.

Annu Rev Public Health. 2002;23:73-91. Epub 2001 Oct 25. Review.

PMID:
11910055
11.

A decade of direct-to-consumer advertising of prescription drugs.

Donohue JM, Cevasco M, Rosenthal MB.

N Engl J Med. 2007 Aug 16;357(7):673-81.

12.

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.

Kim H.

Int J Health Policy Manag. 2015 Aug 25;4(12):813-21. doi: 10.15171/ijhpm.2015.157.

13.

Pharmaceutical direct-to-consumer advertising and US Hispanic patient-consumers.

Barker KK, Vasquez Guzman CE.

Sociol Health Illn. 2015 Nov;37(8):1337-51. doi: 10.1111/1467-9566.12314. Epub 2015 Aug 3.

PMID:
26235537
14.

Market uptake of biologic and small-molecule--targeted oncology drugs in Europe.

Obradovic M, Mrhar A, Kos M.

Clin Ther. 2009 Dec;31(12):2940-52. doi: 10.1016/j.clinthera.2009.12.019.

PMID:
20110034
15.

2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics.

Lindsley CW.

ACS Chem Neurosci. 2014 Apr 16;5(4):250-1. doi: 10.1021/cn500063v. No abstract available.

16.

By the numbers. Top 20 pharmaceutical companies. Ranked by U.S. sales, April 2003 through March 2004.

Moon S.

Mod Healthc. 2004 Aug 16;34(33):40. No abstract available.

PMID:
15356990
17.

When medicine becomes a disease.

[No authors listed]

Arabia. 1986 Mar;5(55):32-6.

PMID:
12340711
18.

The impact of media campaigns on smoking cessation activity: a structural vector autoregression analysis.

Langley TE, McNeill A, Lewis S, Szatkowski L, Quinn C.

Addiction. 2012 Nov;107(11):2043-50. doi: 10.1111/j.1360-0443.2012.03958.x. Epub 2012 Jul 26.

PMID:
22632403
19.

Top 20 pharmaceutical companies. Ranked by U.S. sales, December 2005 to November 2006.

[No authors listed]

Mod Healthc. 2007 Jan 8;37(2):33. No abstract available.

PMID:
17243346
20.

Prescription Drug Promotion from 2001-2014: Data from the U.S. Food and Drug Administration.

Sullivan HW, Aikin KJ, Chung-Davies E, Wade M.

PLoS One. 2016 May 5;11(5):e0155035. doi: 10.1371/journal.pone.0155035. eCollection 2016.

Supplemental Content

Support Center